Migdal Insurance & Financial Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-660
| Closed | -$27K | – | 434 |
|
|
2024
Q2 | $27K | Sell |
660
-700
| -51% | -$28.6K | ﹤0.01% | 340 |
|
|
2024
Q1 | $74K | Hold |
1,360
| – | – | ﹤0.01% | 258 |
|
|
2023
Q4 | $70K | Sell |
1,360
-1,948
| -59% | -$100K | ﹤0.01% | 309 |
|
|
2023
Q3 | $192K | Buy |
3,308
+1,948
| +143% | +$113K | ﹤0.01% | 230 |
|
|
2023
Q2 | $87K | Sell |
1,360
-670
| -33% | -$42.9K | ﹤0.01% | 289 |
|
|
2023
Q1 | $138K | Buy |
2,030
+1,015
| +100% | +$69K | ﹤0.01% | 289 |
|
|
2022
Q4 | $73K | Hold |
1,015
| – | – | ﹤0.01% | 283 |
|
|
2022
Q3 | $73K | Sell |
1,015
-3,135
| -76% | -$225K | ﹤0.01% | 278 |
|
|
2022
Q2 | $320K | Buy |
4,150
+1,259
| +44% | +$97.1K | 0.01% | 206 |
|
|
2022
Q1 | $213K | Buy |
2,891
+2,541
| +726% | +$187K | ﹤0.01% | 267 |
|
|
2021
Q4 | $22K | Sell |
350
-719
| -67% | -$45.2K | ﹤0.01% | 548 |
|
|
2021
Q3 | $63K | Buy |
+1,069
| New | +$63K | ﹤0.01% | 416 |
|
|
2019
Q3 | – | Sell |
-2,671
| Closed | -$120K | – | 745 |
|
|
2019
Q2 | $120K | Buy |
+2,671
| New | +$120K | ﹤0.01% | 548 |
|
|
2018
Q4 | – | Sell |
-11,640
| Closed | -$723K | – | 706 |
|
|
2018
Q3 | $723K | Buy |
11,640
+6,878
| +144% | +$427K | 0.02% | 321 |
|
|
2018
Q2 | $262K | Buy |
4,762
+4,613
| +3,096% | +$254K | 0.01% | 404 |
|
|
2018
Q1 | $9K | Buy |
+149
| New | +$9K | ﹤0.01% | 558 |
|
|
2016
Q3 | – | Sell |
-101,970
| Closed | -$7.54M | – | 110 |
|
|
2016
Q2 | $7.54M | Sell |
101,970
-229,610
| -69% | -$17M | 0.21% | 66 |
|
|
2016
Q1 | $21.3M | Sell |
331,580
-575
| -0.2% | -$36.9K | 0.65% | 32 |
|
|
2015
Q4 | $23M | Buy |
+332,155
| New | +$23M | 0.65% | 37 |
|